🇺🇸 FDA

Intelligence · Patent portfolio

Eton Pharmaceuticals Patents

Full USPTO pharma patent portfolio for Eton Pharmaceuticals — grant dates, expiration, and drug cross-links.

Patents
163
Expiring ≤24m
6

Quick answer

Eton Pharmaceuticals has 163 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 6 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 4

  1. US 10786545

    Use of peptides that block metadherin-SND1 interaction as treatment for cancer

    Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10772862

    Lipid scavenging in Ras cancers

    Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10752626

    Iso-citrate dehydrogenase (IDH) inhibitor

    Expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10745701

    Methods of identifying and treating poor-prognosis cancers

    Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10702569

    Compositions and methods for treatment of pain

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10646475

    SHMT inhibitors

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10596304

    Anti-infective functionalized surfaces and methods of making same

    Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10584132

    SHMT inhibitors

    Expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10543481

    Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10525126

    Modified lipopolysaccharide glycoform and method of use

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10500167

    Droplet-embedded microfibers, and methods and devices for preparing and using same

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10357539

    Use of peptides that block metadherin-SND1 interaction as treatment for cancer

    Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10344064

    Engineered potent cytotoxic stapled BH3 peptides

    Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10324011

    Methods and devices for high throughput purification

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10300130

    Cytomegalovirus vaccines and methods of production

    Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10285978

    Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio

    Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10231937

    Process for encapsulating soluble biologics, therapeutics, and imaging agents

    Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10226487

    Derivation and self-renewal of lsl1+ cells and uses thereof

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10202605

    Methods of identifying and treating poor-prognosis cancers

    Expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10174290

    Method to increase the infectivity of virus particles

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10143219

    Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions

    Expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10130600

    Lipid scavenging in Ras cancers

    Expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10077273

    SHMT inhibitors

    Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10016517

    Bioactive amphiphilic polymer stabilized nanoparticles with enhanced stability and activity

    Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9968587

    Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9956179

    Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use

    Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9943490

    Composite flash-precipitated nanoparticles

    Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9932587

    Methods of identifying and treating poor prognosis cancers

    Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9849133

    Pharmaceutical formulations of xanthine or xanthine derivatives, and their use

    Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9821019

    Compositions and methods for treatment of pain

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9757407

    Treatment of viral infections by modulation of host cell metabolic pathways

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9751851

    Molecules and compositions that inhibit gram negative bacteria and their uses

    Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9677052

    Modified lipopolysaccharide glycoform and method of use

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9572898

    Functionalized fluorine containing phthalocyanine molecules

    Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9573908

    Broad spectrum pro-quorum-sensing molecules as inhibitors of virulence in vibrios

    Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9502638

    Method of manufacturing flexible piezoelectric structures

    Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9468624

    Small molecule antagonists of bacterial quorum-sensing receptors

    Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9464125

    Engineered potent cytotoxic stapled BH3 peptides

    Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9439960

    Cytomegalovirus vaccines and methods of production

    Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9421194

    Lung targeting dual drug delivery system

    Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9415040

    Inhibition of quorum sensing-mediated processes in bacteria

    Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9278116

    Compositions and methods for treatment of pain

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9168269

    Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals

    Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9149445

    Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treatment of viral infections

    Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9084773

    Small molecule antagonists of bacterial quorum-sensing receptors

    Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9072789

    Nano-particle surface modification

    Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9056154

    High-yield activation of polymer surfaces for covalent attachment of molecules

    Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9045476

    Inhibition of quorum sensing-mediated processes in bacteria

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Eton Pharmaceuticals have?

163 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Eton Pharmaceuticals patents expire?

6 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.